{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T23:34:32Z","timestamp":1768433672983,"version":"3.49.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002660","name":"Islamic Azad University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002660","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.bbrc.2023.06.063","type":"journal-article","created":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T20:33:53Z","timestamp":1687206833000},"page":"154-161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Benzenesulfonamide as a novel, pharmaceutical small molecule inhibitor on A\u03b2 gene expression and oxidative stress in Alzheimer's Wistar rats"],"prefix":"10.1016","volume":"674","author":[{"given":"Mahshid","family":"Hesar Shourkabi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Ghobeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanieh","family":"Jafary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2023.06.063_bib1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.gene.2014.05.031","article-title":"Genetic markers for diagnosis and pathogenesis of Alzheimer's disease","volume":"545","author":"Kim","year":"2014","journal-title":"Gene"},{"key":"10.1016\/j.bbrc.2023.06.063_bib2","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ncl.2007.03.008","article-title":"Alzheimer's disease and mild cognitive impairment","volume":"25","author":"Kelley","year":"2007","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.bbrc.2023.06.063_bib3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jalz.2012.11.007","article-title":"The global prevalence of dementia: a systematic review and metaanalysis","volume":"9","author":"Prince","year":"2013","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.bbrc.2023.06.063_bib4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0301-0082(02)00079-5","article-title":"Alzheimer's disease and the basal forebrain cholinergic system: relations to \u03b2-amyloid peptides, cognition, and treatment strategies","volume":"68","author":"Auld","year":"2002","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbrc.2023.06.063_bib5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s11062-012-9309-6","article-title":"Protective effects of troxerutin on \u03b2-amyloid (1-42)-induced impairments of spatial learning and memory in rats","volume":"44","author":"Babri","year":"2012","journal-title":"Neurophysiology"},{"key":"10.1016\/j.bbrc.2023.06.063_bib6","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2023.06.063_bib7","article-title":"Structure and pathology of tau protein in Alzheimer disease","volume":"2012","author":"Kolarova","year":"2012","journal-title":"Int. J. Alzheimer's Dis."},{"key":"10.1016\/j.bbrc.2023.06.063_bib8","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/427318","article-title":"Oxidative stress in Alzheimer's disease: why did antioxidant therapy fail?","volume":"2014","author":"Persson","year":"2014","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.bbrc.2023.06.063_bib9","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1111\/febs.15859","article-title":"Luminescent lanthanide complexes for reactive oxygen species biosensing and possible application in Alzheimer's diseases","volume":"289","author":"Galaup","year":"2022","journal-title":"FEBS J."},{"key":"10.1016\/j.bbrc.2023.06.063_bib10","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cell.2005.02.008","article-title":"Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective","volume":"120","author":"Tanzi","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2023.06.063_bib11","doi-asserted-by":"crossref","first-page":"6915","DOI":"10.1523\/JNEUROSCI.0340-17.2017","article-title":"BACE1 cleavage site selection critical for amyloidogenesis and Alzheimer's pathogenesis","volume":"37","author":"Zhang","year":"2017","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.bbrc.2023.06.063_bib12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1358\/dnp.2004.17.5.829036","article-title":"The inhibition of gamma-secretase as a therapeutic approach to Alzheimer's disease","volume":"17","author":"Tomita","year":"2004","journal-title":"Drug News Perspect."},{"key":"10.1016\/j.bbrc.2023.06.063_bib13","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1124\/jpet.109.152975","article-title":"Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein \u03b3-secretase for the treatment of Alzheimer's disease","volume":"331","author":"Martone","year":"2009","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.bbrc.2023.06.063_bib14","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Mechanisms of disease Alzheimer's disease","volume":"362","author":"Henry","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2023.06.063_bib15","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3389\/fnins.2016.00178","article-title":"Alzheimer's disease and hippocampal adult neurogenesis; exploring shared mechanisms","volume":"10","author":"Hollands","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbrc.2023.06.063_bib16","doi-asserted-by":"crossref","first-page":"268","DOI":"10.2174\/157018006776743215","article-title":"Recent developments in natural and synthetic drug research for Alzheimer's disease","volume":"3","author":"Orhan","year":"2006","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.bbrc.2023.06.063_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejphar.2009.10.020","article-title":"Searching for new animal models of Alzheimer' s disease","volume":"626","author":"Epis","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2023.06.063_bib18","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3233\/JAD-2010-100078","article-title":"Effect of donepezil on cognition in severe Alzheimer's disease: a pooled data analysis","volume":"21","author":"Cummings","year":"2010","journal-title":"J.\u00a0Alzheim. Dis."},{"key":"10.1016\/j.bbrc.2023.06.063_bib20","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/35067589","article-title":"Acetylcholinesterase-new roles for an old actor","volume":"2","author":"Soreq","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbrc.2023.06.063_bib19","doi-asserted-by":"crossref","first-page":"17213","DOI":"10.1073\/pnas.0508575102","article-title":"Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer \u03b2-amyloid peptide in rodent","volume":"102","author":"Greig","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2023.06.063_bib21","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.coph.2005.01.014","article-title":"Acetylcholinesterase:\u2018classical\u2019and \u2018non-classical\u2019functions and pharmacology","volume":"5","author":"Silman","year":"2005","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.bbrc.2023.06.063_bib22","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrn1035","article-title":"Neurobiology of butyrylcholinesterase","volume":"4","author":"Darvesh","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbrc.2023.06.063_bib23","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd1330","article-title":"Neurodegenerative diseases and oxidative stress","volume":"3","author":"Barnham","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2023.06.063_bib24","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s10072-016-2625-7","article-title":"Current pharmacotherapy and putative disease-modifying therapy for Alzheimer's disease","volume":"37","author":"Kulshreshtha","year":"2016","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.bbrc.2023.06.063_bib25","doi-asserted-by":"crossref","first-page":"40810","DOI":"10.1074\/jbc.M205659200","article-title":"Structural and dynamic features of Alzheimer's A\u03b2 peptide in amyloid fibrils studied by site-directed spin labeling","volume":"277","author":"Torok","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2023.06.063_bib26","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1021\/bi3012059","article-title":"Diaryl hydrazones as multifunctional inhibitors of amyloid self-assembly","volume":"52","author":"T\u00f6r\u00f6k","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbrc.2023.06.063_bib27","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.bmcl.2014.12.006","article-title":"Sulfonamides as multifunctional agents for Alzheimer's disease","volume":"25","author":"Bag","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.bbrc.2023.06.063_bib28","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s13311-020-00841-6","article-title":"Direct activation of protein phosphatase 2A (PP2A) by tricyclic sulfonamides ameliorates Alzheimer's disease pathogenesis in cell and animal models","volume":"17","author":"Wei","year":"2020","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.bbrc.2023.06.063_bib29","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1128\/br.7.4.175-262.1943","article-title":"The mode of action of sulfonamides","volume":"7","author":"Henry","year":"1943","journal-title":"Bacteriol. Rev."},{"key":"10.1016\/j.bbrc.2023.06.063_bib30","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3109\/14756366.2012.692087","article-title":"Synthesis, characterization and antimicrobial activity of novel xanthene sulfonamide and carboxamide derivatives","volume":"28","author":"Kaya","year":"2013","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.bbrc.2023.06.063_bib31","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1517\/13543776.2013.798648","article-title":"Anticancer carbonic anhydrase inhibitors: a patent review","volume":"23","author":"Monti","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bbrc.2023.06.063_bib32","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1021\/jm021123s","article-title":"Carbonic anhydrase inhibitors. Inhibition of tumor-associated isozyme IX by halogenosulfanilamide and halogenophenylaminobenzolamide derivatives","volume":"46","author":"Ilies","year":"2003","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.bbrc.2023.06.063_bib33","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1517\/13543776.2013.790957","article-title":"Antiobesity carbonic anhydrase inhibitors: a literature and patent review","volume":"23","author":"Scozzafava","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bbrc.2023.06.063_bib34","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3390\/molecules22040535","article-title":"Novel sulfamethoxazole ureas and oxalamide as potential antimycobacterial agents","volume":"22","author":"Kr\u00e1tk\u00fd","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2023.06.063_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202000496","article-title":"Synthesis of novel sulfonamides with anti-Alzheimer and antioxidant capacities","volume":"354","author":"G\u00f6k","year":"2021","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bbrc.2023.06.063_bib36","first-page":"620","article-title":"Biological activity and synthesis of sulfonamide derivatives: a brief review","volume":"68","author":"Ko\u0142aczek","year":"2014","journal-title":"Chem"},{"key":"10.1016\/j.bbrc.2023.06.063_bib37","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejmech.2014.05.039","article-title":"Carbonic anhydrase inhibitors. Synthesis of a novel series of 5-substituted 2, 4-dichlorobenzenesulfonamides and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII","volume":"82","author":"S\u0142awi\u0144ski","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbrc.2023.06.063_bib38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejmech.2014.06.074","article-title":"Synthesis of a new series of N4-substituted 4-(2-aminoethyl) benzenesulfonamides and their inhibitory effect on human carbonic anhydrase cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII","volume":"84","author":"S\u0142awi\u0144ski","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbrc.2023.06.063_bib39","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.bmcl.2003.12.086","article-title":"A\u03b2 Aggregation inhibitors. Part 1: synthesis and biological activity of phenylazo benzenesulfonamides","volume":"14","author":"Lin","year":"2004","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.bbrc.2023.06.063_bib40","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.2174\/092986706776360978","article-title":"Oxidative stress in Alzheimer patients in different stages of the disease","volume":"13","author":"Zafrilla","year":"2006","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbrc.2023.06.063_bib41","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000213853","article-title":"Determination of Malonaldehyde in Alzheimer's disease: a comparative study of high-performance liquid chromatography and tiobarbituric acid test","volume":"43","author":"Bermejo","year":"1997","journal-title":"Gerontology"},{"key":"10.1016\/j.bbrc.2023.06.063_bib42","first-page":"453","article-title":"[Malondialdehyde (MDA) as a lipid peroxidation marker]","volume":"57","author":"Gawe\u0142","year":"2004","journal-title":"Wiad. Lek."},{"issue":"6","key":"10.1016\/j.bbrc.2023.06.063_bib43","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1055\/s-2005-916186","article-title":"Enhanced ROS-generation in lymphocytes from Alzheimer's disease","volume":"38","author":"Leutner","year":"2005","journal-title":"Pharmacopsychiatry"},{"issue":"7","key":"10.1016\/j.bbrc.2023.06.063_bib44","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0197-4580(03)00031-9","article-title":"Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease","volume":"24","author":"Rinaldi","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbrc.2023.06.063_bib45","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.2174\/092986706776360978","article-title":"Oxidative stress in Alzheimer patients in different stages of the disease","volume":"13","author":"Zafrilla","year":"2006","journal-title":"Curr. Med. Chem."},{"issue":"3","key":"10.1016\/j.bbrc.2023.06.063_bib46","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.bmcl.2014.12.006","article-title":"Sulfonamides as multifunctional agents for Alzheimer's disease","volume":"25","author":"Bag","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"24","key":"10.1016\/j.bbrc.2023.06.063_bib47","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.4155\/fmc-2019-0106","article-title":"Multifunctional hybrid sulfonamides as novel therapeutic agents for Alzheimer's disease","volume":"11","author":"Swetha","year":"2019","journal-title":"Future Med. Chem."},{"issue":"7","key":"10.1016\/j.bbrc.2023.06.063_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202000496","article-title":"Synthesis of novel sulfonamides with anti-Alzheimer and antioxidant capacities","volume":"354","author":"G\u00f6k","year":"2021","journal-title":"Arch. Pharmazie"},{"key":"10.1016\/j.bbrc.2023.06.063_bib49","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.pbb.2005.06.007","article-title":"Neuroprotection by crocetin in a hemi-parkinsonian rat model","volume":"81","author":"Ahmad","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbrc.2023.06.063_bib50","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/jnr.20280","article-title":"Peroxide detoxification by brain cells","volume":"79","author":"Dringen","year":"2005","journal-title":"J.\u00a0Neurosci. Res."},{"issue":"3","key":"10.1016\/j.bbrc.2023.06.063_bib51","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s11064-007-9453-3","article-title":"Lipid peroxidation and antioxidant enzyme activities in vascular and Alzheimer dementias","volume":"33","author":"Casado","year":"2008","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbrc.2023.06.063_bib52","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000213037","article-title":"Lipid peroxidation and free radical scavengers in Alzheimer's disease","volume":"35","author":"Jeandel","year":"1989","journal-title":"Gerontology"},{"issue":"2","key":"10.1016\/j.bbrc.2023.06.063_bib53","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1039\/D0MD00009D","article-title":"Structure-activity relationships of sulfonamides derived from carvacrol and their potential for the treatment of Alzheimer's disease","volume":"11","author":"de Souza","year":"2020","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.bbrc.2023.06.063_bib54","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neuron.2004.09.010","article-title":"Deciphering the molecular basis of memory failure in Alzheimer's disease","volume":"44","author":"Walsh","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2023.06.063_bib55","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12868-015-0211-1","article-title":"Neuronal response in Alzheimer's and Parkinson's disease: the effect of toxic proteins on intracellular pathways","volume":"16","author":"Majd","year":"2015","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.bbrc.2023.06.063_bib56","first-page":"3460","article-title":"Neuroprotective role of antidiabetic drug metformin against amyloid \u03b2peptide-induced neuronal loss in hippocampal CA1 pyramidal neurons in rats fed high fat diet","volume":"9","author":"Asadbegi","year":"2016","journal-title":"J.\u00a0Chem. Pharmaceut. Sci."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X23008185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X23008185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:31:57Z","timestamp":1757766717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X23008185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":56,"alternative-id":["S0006291X23008185"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2023.06.063","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Benzenesulfonamide as a novel, pharmaceutical small molecule inhibitor on A\u03b2 gene expression and oxidative stress in Alzheimer's Wistar rats","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2023.06.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}